Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant

References

• Rudiger T, Weisenburger DD, Anderson JR, . Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002;13:140–149.
   PubMed Web of Science ®Google Scholar
• Gisselbrecht C, Gaulard P, Lepage E, . Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA). Blood 1998;92:76–82.
   PubMed Web of Science ®Google Scholar
• Savage KJ, Harris NL, Vose JM, . ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008;111:5496–5504.
   PubMed Web of Science ®Google Scholar
• Suzumiya J, Ohshima K, Tamura K, . The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 2009;20:715–721.
   PubMed Web of Science ®Google Scholar
• Reimer P, Rudiger T, Geissinger E, . Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol 2009;27: 106–113.
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Munsell M, Yazji S, . Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19:3766–3770.
   PubMed Web of Science ®Google Scholar
• Corradini P, Dodero A, Zallio F, . Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004;22:2172–2176.
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Milpied N, Buzyn A, . Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 2008;26:2264–2271.
   PubMed Web of Science ®Google Scholar
• Hishizawa M, Kanda J, Utsunomiya A, . Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010;116:1369–1376.
   PubMed Web of Science ®Google Scholar
• Jacobsen ED, Kim HT, Ho VT, . A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome. Ann Oncol 2011;22:1608–1613.
   PubMed Web of Science ®Google Scholar
• Ansell SM, Habermann TM, Kurtin PJ, . Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997;15:2296–2301.
   PubMed Web of Science ®Google Scholar
• Perales MA, Jenq R, Goldberg JD, . Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplant 2010;45:1408–1416.
   PubMed Web of Science ®Google Scholar
• Gallamini A, Stelitano C, Calvi R, . Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004;103:2474–2479.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Ballen K, Rizzo D, . Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009;15:1628–1633.
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, . IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997;97:855–864.
   PubMed Web of Science ®Google Scholar
• Papadopoulos EB, Carabasi MH, Castro-Malaspina H, . T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998;91:1083–1090.
   PubMed Web of Science ®Google Scholar
• Jakubowski AA, Small TN, Young JW, . T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007;110:4552–4559.
   PubMed Web of Science ®Google Scholar
• Kernan NA, Flomenberg N, Collins NH, . Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation 1985;40:317–322.
   PubMed Web of Science ®Google Scholar
• Barker JN, Doubrovina E, Sauter C, . Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood 2010;116:5045–5049.
   PubMed Web of Science ®Google Scholar
• Burt RK, Guitart J, Traynor A, . Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect. Bone Marrow Transplant 2000;25:111–113.
   PubMed Web of Science ®Google Scholar
• Herbert KE, Spencer A, Grigg A, . Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation. Bone Marrow Transplant 2004;34:521–525.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim BS, Choi CW, . Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. Ann Oncol 2007;18:1382–1387.
   PubMed Web of Science ®Google Scholar
• Went P, Agostinelli C, Gallamini A, . Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006;24:2472–2479.
   PubMed Web of Science ®Google Scholar